- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03693820
Gall Bladder Bed Infiltration Analgesia
The Effect of Gallbladder Bed Infiltration on Analgesia in Laparoscopic Cholecystectomy
연구 개요
상세 설명
Bladder bed irrigation with Bupivacaine was an effective method for reducing pain during the first postoperative hours after laparoscopic cholecystectomy. The intraperitoneal administration of lidocaine solution (total dose, 3.5 mg/kg) will be done as follows: immediately after creation of the pneumoperitoneum, the surgeon will spray 50-75 ml of the total solution on the upper surface of the liver under the right sub-diaphragmatic space, and another 50-75ml of the total solution under the left sub-diaphragmatic space. In order to allow the sprayed solution to diffuse under the diaphragmatic space, the Trendelenburg position will be maintained for 2 minutes.
In the infiltration group will be administrating 5 ml lidocaine at each port site before incision, then the surgeon will spray 50-75 ml of the total solution on the upper surface of the liver under the right sub-diaphragmatic space, and another 50-75ml of the total solution under the left sub-diaphragmatic space then 50 ml will be infiltrated in the bladder bed after clamping of the cystic duct and cystic artery. CO2 will be humidified and wormed.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Al-Dakahleia
-
Mansourah, Al-Dakahleia, 이집트, 35516
- Gastro-enterolgy surgical center, Mansoura University
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Scheduled to undergo elective laparoscopic cholecystectomy.
- American Society of Anesthesiologists physical status (ASA) I or II.
Exclusion Criteria:
- Patient in receipt of analgesics or sedatives 24 h before scheduled surgery.
- Patient with spillage or cholelithiasis with known common bile duct pathology.
- Body Mass Index > 40 Kg/m2.
- Patient underlying severe systemic disease.
- Patient with a history of abdominal surgery, a chronic pain disorder other than gallbladder disease or allergy to lidocaine.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: the infiltration group
a cocktail of 5 mg/Kg lidocaine normal saline in a volume of 3 ml/Kg 5 mcg/ml adrenaline.
We will administrate 5 ml lidocaine at each port site before incision, then immediately after the creation of the pneumoperitoneum, the surgeon will spray 50-75 ml of the total solution on the upper surface of the liver under the right sub-diaphragmatic space and another 50-75ml over the parietal peritoneum.
The Trendelenburg position will be maintained for 2 minutes.
Then 50 ml will be infiltrated in the bladder bed and pedicle after clamping of the cystic duct and artery.
Infiltration will be through a laparoscopic suction needle, diameter 0.9 /330 mm (Zhejiang, China).
|
|
|
위약 비교기: the control group
the same technique but the 50 ml for gallbladder infiltration will be replaced by saline.
|
the 50 ml prepared for gallbladder bed infiltration will be replaced by saline.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The total postoperative analgesic consumption
기간: postoperative, for 24 hours
|
ketorolac and morphine in mg .
|
postoperative, for 24 hours
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The time to the first request of analgesia
기간: postoperative, for 24 hours
|
hours
|
postoperative, for 24 hours
|
|
The intraoperative fentanyl requirements.
기간: intraoperative
|
microgram
|
intraoperative
|
|
postoperative pain score: VAS
기간: postoperative at 0, 2, 4, 8, 12, 16 and 24 hours
|
visual analog score from 0-10, zero is no pain, 10 is the most imaginable pain,
|
postoperative at 0, 2, 4, 8, 12, 16 and 24 hours
|
|
heart rate
기간: basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.
|
beat/ minute
|
basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.
|
|
mean blood pressure
기간: basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.
|
mmHg
|
basal and intraoperatively every 30 minutes, then at 0, 2, 4, 8, 12, 16 and 24 hours post-operatively.
|
|
incidence of vomiting
기간: postoperatively, during the first 24 hours
|
number
|
postoperatively, during the first 24 hours
|
|
the sleep quality
기간: postoperatively, after the first night.
|
through a score 0-2, where 0= good quite sleep, 1= fair sleep, 2= bad quality of sleep.
|
postoperatively, after the first night.
|
|
Patient satisfaction regards analgesia:
기간: postoperative after 24 hour.
|
using visual analog score from 0-10.
zero = no satisfaction, 12= maximum satisfaction.
|
postoperative after 24 hour.
|
|
Surgeon satisfaction regards the technique:
기간: postoperative within 1 hour.
|
using visual analog score from 0-10.
zero = no satisfaction, 10= maximum satisfaction.
|
postoperative within 1 hour.
|
공동 작업자 및 조사자
스폰서
수사관
- 연구 책임자: alaa mazy, MD, faculty of medicine, Mansoura
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- MS.18.09.277
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .